Novartis AG said its Gilenya drug to treat multiple sclerosis helped slow brain loss, a measure linked to the severity of the disease.
Patients taking Gilenya in three large Novartis-led studies lost a third less brain volume than patients taking either a placebo or Biogen Idec Inc. Avonex, Novartis said in an e- mailed statement today..... Read More - http://www.ms-uk.org/index.cfm/gilenya
Oral MS drug, Gilenya, Slowed Brain Loss in Study
Oral MS drug, Gilenya, Slowed Brain Loss in Study
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1258 Views
-
Last post by frodo
-
- 1 Replies
- 1017 Views
-
Last post by Petr75
-
- 5 Replies
- 11271 Views
-
Last post by gibbledygook
-
- 2 Replies
- 1974 Views
-
Last post by NHE
-
- 0 Replies
- 1296 Views
-
Last post by NHE
-
- 6 Replies
- 3230 Views
-
Last post by NHE
-
- 0 Replies
- 1501 Views
-
Last post by frodo
-
- 1 Replies
- 2700 Views
-
Last post by Tif
-
- 0 Replies
- 1588 Views
-
Last post by NHE